RS
Rajanikanta Samantray
About Rajanikanta Samantray
Data last updated:
Rajanikanta Samantray is a Director at Kar Medical Private Limited (since 2016) and Director at Pharmazone Lab Limited (since 2014). The companies operate in Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹3.16 Cr; the largest is Kar Medical Private Limited at ₹1.82 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Feb 2016 | 2007 | ₹1.82 Cr (FY 2025) | Active | |
| Director | 13 Nov 2014 | 2014 | ₹1.34 Cr (FY 2023) | Active |
Board colleagues of Rajanikanta Samantray
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prabhash Tirth Pani | 03202727 | Kar Medical Private Limited , Pharmazone Lab Limited | Director |
| Mohammed Kasim | 07980093 | Pharmazone Lab Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajanikanta Samantray
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajanikanta Samantray
Rajanikanta Samantray currently holds 2 directorships: Kar Medical Private Limited (Director, since 01 Feb 2016, revenue ₹1.82 Cr (FY 2025)); Pharmazone Lab Limited (Director, since 13 Nov 2014, revenue ₹1.34 Cr (FY 2023)).
Rajanikanta Samantray was first appointed on 13 Nov 2014 as Director at Pharmazone Lab Limited. The most recent appointment on record is 01 Feb 2016 at Kar Medical Private Limited.
The 2 current companies of Rajanikanta Samantray that report revenue have a combined latest revenue of ₹3.16 Cr: Kar Medical Private Limited ₹1.82 Cr (FY 2025); Pharmazone Lab Limited ₹1.34 Cr (FY 2023).
The current boards of Rajanikanta Samantray's companies include Prabhash Tirth Pani (Kar Medical Private Limited), Mohammed Kasim (Pharmazone Lab Limited).